Fed. Circ. Remands Ferring Drug Patent Inventorship Fight
Law360 (November 10, 2020, 8:31 PM EST) -- The Federal Circuit said Tuesday that a New York federal judge was too quick to grant summary judgment in a case where Ferring Pharmaceuticals challenged the inventorship of three patents that an ex-employee sold to Allergan in a $43 million deal in 2010.
While the lower court found that Ferring was barred by equitable estoppel from raising these claims because it engaged in misleading conduct, the Federal Circuit said in a 29-page precedential opinion that further proceedings are required because disputed issues of fact remain, including questions concerning the misleading conduct determination.
"Where the matter adjudged is a quintessentially fact-laden one, such as...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!